dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration
- PMID: 23408943
- PMCID: PMC3567092
- DOI: 10.1371/journal.pone.0054511
dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. We previously showed that the expression of dynactin 1, an axon motor protein regulating retrograde transport, is markedly reduced in spinal motor neurons of sporadic ALS patients, although the mechanisms by which decreased dynactin 1 levels cause neurodegeneration have yet to be elucidated. The accumulation of autophagosomes in degenerated motor neurons is another key pathological feature of sporadic ALS. Since autophagosomes are cargo of dynein/dynactin complexes and play a crucial role in the turnover of several organelles and proteins, we hypothesized that the quantitative loss of dynactin 1 disrupts the transport of autophagosomes and induces the degeneration of motor neuron. In the present study, we generated a Caenorhabditis elegans model in which the expression of DNC-1, the homolog of dynactin 1, is specifically knocked down in motor neurons. This model exhibited severe motor defects together with axonal and neuronal degeneration. We also observed impaired movement and increased number of autophagosomes in the degenerated neurons. Furthermore, the combination of rapamycin, an activator of autophagy, and trichostatin which facilitates axonal transport dramatically ameliorated the motor phenotype and axonal degeneration of this model. Thus, our results suggest that decreased expression of dynactin 1 induces motor neuron degeneration and that the transport of autophagosomes is a novel and substantial therapeutic target for motor neuron degeneration.
Conflict of interest statement
Figures











Similar articles
-
[Dysfunction of dynactin 1 in motor neuron degeneration].Rinsho Shinkeigaku. 2013;53(11):1084-6. doi: 10.5692/clinicalneurol.53.1084. Rinsho Shinkeigaku. 2013. PMID: 24291886 Review. Japanese.
-
A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease.Sci Rep. 2019 Jul 12;9(1):10104. doi: 10.1038/s41598-019-46642-6. Sci Rep. 2019. PMID: 31300701 Free PMC article.
-
A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.Hum Mol Genet. 2008 Sep 15;17(18):2849-62. doi: 10.1093/hmg/ddn182. Epub 2008 Jun 25. Hum Mol Genet. 2008. PMID: 18579581
-
Insights on UNC-104-dynein/dynactin interactions and their implications on axonal transport in Caenorhabditis elegans.J Neurosci Res. 2019 Feb;97(2):185-201. doi: 10.1002/jnr.24339. Epub 2018 Oct 12. J Neurosci Res. 2019. PMID: 30311677
-
Cytoplasmic dynein/dynactin function and dysfunction in motor neurons.Int J Dev Neurosci. 2006 Apr-May;24(2-3):103-11. doi: 10.1016/j.ijdevneu.2005.11.013. Epub 2006 Jan 6. Int J Dev Neurosci. 2006. PMID: 16406469 Review.
Cited by
-
Rint1 inactivation triggers genomic instability, ER stress and autophagy inhibition in the brain.Cell Death Differ. 2016 Mar;23(3):454-68. doi: 10.1038/cdd.2015.113. Epub 2015 Sep 18. Cell Death Differ. 2016. PMID: 26383973 Free PMC article.
-
Mechanisms of aging-related proteinopathies in Caenorhabditis elegans.Exp Mol Med. 2016 Oct 7;48(10):e263. doi: 10.1038/emm.2016.109. Exp Mol Med. 2016. PMID: 27713398 Free PMC article. Review.
-
Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway.Nat Commun. 2016 Jun 10;7:11808. doi: 10.1038/ncomms11808. Nat Commun. 2016. PMID: 27283760 Free PMC article.
-
Amyotrophic Lateral Sclerosis Mechanism: Insights from the Caenorhabditis elegans Models.Cells. 2024 Jan 3;13(1):99. doi: 10.3390/cells13010099. Cells. 2024. PMID: 38201303 Free PMC article. Review.
-
Phenotypic Screening in C. elegans as a Tool for the Discovery of New Geroprotective Drugs.Pharmaceuticals (Basel). 2020 Jul 25;13(8):164. doi: 10.3390/ph13080164. Pharmaceuticals (Basel). 2020. PMID: 32722365 Free PMC article. Review.
References
-
- Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885–889. - PubMed
-
- Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880–884. - PubMed
-
- Ravikumar B, Acevedo-Arozena A, Imarisio S, Berger Z, Vacher C, et al. (2005) Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat Genet 37: 771–776. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous